Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy

NCT02422498 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Locally Recurrent/Metastatic Triple Negative Breast Cancer

Interventions

RADIATION: external beam radiation therapy
DRUG: cisplatin
PROCEDURE: Biopsy of Target Tumor

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]